Holly Fernandez Lynch is Executive Director at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and a member of the faculty at Harvard Medical School's Center for Bioethics.
Barbara E. Bierer is Professor of Medicine at Harvard Medical School and Brigham and Women's Hospital and Faculty Codirector of the Multi-Regional Clinical Trials Center.
I. Glenn Cohen is Professor at Harvard Law School and Faculty Director at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.
Suzanne M. Rivera is Vice President for Research and Technology Management and Assistant Professor of Bioethics and Pediatrics at Case Western Reserve University.
5: Biospecimens, Commercial Research, and the Elusive Public Benefit Standard
-
Published:2017
Barbara J. Evans, Eric M. Meslin, 2017. "Biospecimens, Commercial Research, and the Elusive Public Benefit Standard", Specimen Science: Ethics and Policy Implications, Holly Fernandez Lynch, Barbara E. Bierer, I. Glenn Cohen, Suzanne M. Rivera
Download citation file: